Please check your internet connection and try again.
# Arsil-DX (Dextromethorphan/Chlorpheniramine/Phenylephrine)
## Overview
Arsil-DX is a multi-ingredient over-the-counter (OTC) combination product used for the temporary relief of upper respiratory symptoms. It typically consists of an antitussive (dextromethorphan), a first-generation antihistamine (chlorpheniramine), and a sympathomimetic decongestant (phenylephrine).
## Primary Indications
Symptomatic relief of cough, sneezing, runny nose, congestion, and itchy/watery eyes associated with the common cold, allergic rhinitis, or upper respiratory allergies.
## Adult Dosing
* **Standard Dose:** 10 mL (or typical manufacturer-defined unit dose) orally every 4 to 6 hours.
* **Maximum Dose:** Do not exceed 4 doses (40 mL) in a 24-hour period.
## Pediatric Dosing
* **Children 6 to 12 years:** 5 mL orally every 4 to 6 hours. Do not exceed 20 mL in 24 hours.
* **Children under 6 years:** Not recommended. The FDA and AAP advise against using OTC cough and cold products in children under 6 due to lack of efficacy and risk of serious side effects (e.g., sedation, arrhythmias).
## Dose Adjustments
* **Renal/Hepatic Impairment:** No standard guidelines exist; use with caution. Elderly patients may be more sensitive to the anticholinergic effects of chlorpheniramine.
* **Geriatric:** Start at the lowest effective dose due to increased risk of confusion, urinary retention, and orthostatic hypotension.
## Contraindications
* Hypersensitivity to any component.
* Concurrent use of monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuation (risk of hypertensive crisis/serotonin syndrome).
* Severe hypertension or coronary artery disease (due to phenylephrine).
* Narrow-angle glaucoma or urinary retention (due to chlorpheniramine).
## Adverse Effects
* **Common:** Drowsiness, dizziness, dry mouth, blurred vision, thick bronchial secretions.
* **Serious:** Tachycardia, palpitations, hypertension, paradoxical excitation (especially in children), urinary retention.
## Key Drug Interactions
* **MAOIs:** Absolute contraindication (hypertensive crisis).
* **CNS Depressants:** Alcohol, benzodiazepines, or opioids may potentiate sedative effects.
* **Anticholinergics:** May exacerbate side effects like urinary retention or dry mouth.
* **Hypertensive Agents:** May antagonize antihypertensive therapy.
## Monitoring
* Monitor blood pressure and heart rate, particularly in hypertensive patients.
* Assess for relief of respiratory symptoms vs. development of side effects.
* Educate patients to avoid driving or operating machinery if sedation occurs.
## Clinical Pearls
* Many multi-symptom products contain overlapping ingredients; screen medication history to prevent synergistic toxicity.
* Phenylephrine has limited efficacy as an oral decongestant at standard doses compared to pseudoephedrine.
* Advise against alcohol consumption due to the additive CNS-depressant effects of chlorpheniramine.
* If symptoms persist beyond 7 days or are accompanied by high fever, advise the patient to seek medical evaluation.
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult current institutional protocols, local formularies, and the manufacturer’s package insert before prescribing or administering medication. Clinical judgment should prevail based on individual patient assessment.
